These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25396098)

  • 1. Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.
    Martínez AK; Maroni L; Marzioni M; Ahmed ST; Milad M; Ray D; Alpini G; Glaser SS
    Curr Pathobiol Rep; 2014 Dec; 2(4):143-153. PubMed ID: 25396098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics.
    Moscoso CG; Steer CJ
    Hepat Med; 2019; 11():109-129. PubMed ID: 31565001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cells as a target for the treatment of liver fibrosis.
    Bataller R; Brenner DA
    Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
    Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
    J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
    Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell.
    Gäbele E; Brenner DA; Rippe RA
    Front Biosci; 2003 Jan; 8():d69-77. PubMed ID: 12456323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic stellate cells and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the renin-angiotensin system in liver fibrosis.
    Munshi MK; Uddin MN; Glaser SS
    Exp Biol Med (Maywood); 2011 May; 236(5):557-66. PubMed ID: 21508249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice.
    Hintermann E; Bayer M; Conti CB; Fuchs S; Fausther M; Leung PS; Aurrand-Lions M; Taubert R; Pfeilschifter JM; Friedrich-Rust M; Schuppan D; Dranoff JA; Gershwin ME; Manns MP; Imhof BA; Christen U
    J Autoimmun; 2018 Jul; 91():83-96. PubMed ID: 29753567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
    Perugorria MJ; Latasa MU; Nicou A; Cartagena-Lirola H; Castillo J; Goñi S; Vespasiani-Gentilucci U; Zagami MG; Lotersztajn S; Prieto J; Berasain C; Avila MA
    Hepatology; 2008 Oct; 48(4):1251-61. PubMed ID: 18634036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTHRC1 expression in primary biliary cholangitis.
    Li YK; Li YM; Li Y; Wei YR; Zhang J; Li B; You ZR; Chen Y; Huang BY; Miao Q; Wang QX; Peng YS; Gershwin ME; Tang RQ; Bian ZL; Ma X
    J Dig Dis; 2019 Jul; 20(7):371-376. PubMed ID: 31102333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Liver Fibrosis.
    Pinzani M
    Dig Dis; 2015; 33(4):492-7. PubMed ID: 26159264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stellate cell activation in alcoholic fibrosis--an overview.
    Friedman SL
    Alcohol Clin Exp Res; 1999 May; 23(5):904-10. PubMed ID: 10371412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 2 Promotes Hepatic Regulatory T Cell Responses and Protects From Biliary Fibrosis in Murine Sclerosing Cholangitis.
    Taylor AE; Carey AN; Kudira R; Lages CS; Shi T; Lam S; Karns R; Simmons J; Shanmukhappa K; Almanan M; Chougnet CA; Miethke AG
    Hepatology; 2018 Nov; 68(5):1905-1921. PubMed ID: 29698570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on implications and mechanisms of angiogenesis in liver fibrosis.
    Zhang Z; Zhang F; Lu Y; Zheng S
    Hepatol Res; 2015 Jan; 45(2):162-78. PubMed ID: 25196587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.